How is the Akero Therapeutics Inc today?

The Akero Therapeutics Inc today is trading in the green, up by 1.73% at 51.61.

How has Akero Therapeutics Inc performed historically?

The Akero Therapeutics Inc is currently trading up 1.73% on an intraday basis in the past week the index rose 11.32%. The index has been up 5.07% in the past quarter and rose 174.23% in the past year. You can view this in the overview section.

What is Akero Therapeutics Inc Annual Net Profit?

Akero Therapeutics Inc Annual Net Profit fell 66.09% in the last year to $252.06 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Akero Therapeutics Inc Price to Earning Ratio?

Akero Therapeutics Inc Price to Earning Ratio is -15.27, which is negative.

What is Akero Therapeutics Inc Stock Price?

Akero Therapeutics Inc Stock Price rose 174.23% and outperformed its sector by 149.18% in the past year.

What is Akero Therapeutics Inc Quarterly Net profit?

Akero Therapeutics Inc Quarterly Net profit fell 32.58% YoY to $70.72 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Akero Therapeutics Inc Debt to Equity Ratio?

Akero Therapeutics Inc Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Akero Therapeutics Inc Return on Equity(ROE)?

Akero Therapeutics Inc Return on Equity(ROE) for the last financial year was -39.22%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Akero Therapeutics Inc Mutual Fund Holding?

Akero Therapeutics Inc Mutual Fund Holding decreased by 1.58% in the last quarter to 56.95.

What is Akero Therapeutics Inc Promoter Share Holding?

Akero Therapeutics Inc Promoter Share Holding decreased by 0.5% in the most recent quarter to 4.61%.

What is Akero Therapeutics Inc Interest Coverage Ratio?

Akero Therapeutics Inc Interest Coverage Ratio is -53, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Akero Therapeutics Inc Institutional Holding?

Akero Therapeutics Inc Institutional Holding increased by 12.85% in the last quarter to 108.02.

Akero Therapeutics Inc XNAS: AKRO

Akero Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Akero Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Akero Therapeutics Inc
Rating: 1.84341675
Author: Trendlyne DVM scores

about

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NA...

51.61 0.88 (1.73%)

188.97% Gain from 52W Low

2.1M XNAS Volume

XNAS 03 Jun, 2025 4:16 PM (EDT)

Board Meeting

The next board meeting for Akero Therapeutics Inc is on 06 Jun 2025 for the purpose of Akero Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

3.7 / 100

Technically Bullish

70.1 / 100

No estimates available

Akero Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Akero Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NA...

188.97% Gain from 52W Low

SWOT Analysis

Akero Therapeutics Inc Live Price Chart

Akero Therapeutics Inc FAQ

How is Akero Therapeutics Inc today?

Akero Therapeutics Inc today is trading in the green, and is up by 1.73% at 51.61.

How has Akero Therapeutics Inc performed historically?

Akero Therapeutics Inc is currently trading up 1.73% on an intraday basis. In the past week the stock rose 11.32%. stock has been up 5.07% in the past quarter and rose 174.23% in the past year. You can view this in the overview section.